항EGFR 항체의 방사성 복합체 및 방사성 의약

본 발명은, 약효를 손상시키는 일 없이 종래보다도 안정성이 높여진 복합체를 제공하는 것을 과제로 한다. 본 발명의 복합체는, 펩티드로 부위 특이적으로 수식된 항EGFR 항체와 킬레이트제의 복합체이며, 킬레이트제에 방사성 금속 핵종이 킬레이트화되어 있고, 펩티드와 킬레이트제가 링커(L)를 통해 연결되어 있고, 링커(L)는 티오우레아 결합을 포함하지 않는다. A conjugate having stability improved more than conventional conjugates without impairing the effica...

Full description

Saved in:
Bibliographic Details
Main Authors KAWATANI MINORU, TONOYA GOTA, HANADA TAKAHISA, TAKEDA TAKUYA
Format Patent
LanguageKorean
Published 30.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은, 약효를 손상시키는 일 없이 종래보다도 안정성이 높여진 복합체를 제공하는 것을 과제로 한다. 본 발명의 복합체는, 펩티드로 부위 특이적으로 수식된 항EGFR 항체와 킬레이트제의 복합체이며, 킬레이트제에 방사성 금속 핵종이 킬레이트화되어 있고, 펩티드와 킬레이트제가 링커(L)를 통해 연결되어 있고, 링커(L)는 티오우레아 결합을 포함하지 않는다. A conjugate having stability improved more than conventional conjugates without impairing the efficacy is provided by the present invention. The conjugate of the present invention is a conjugate of an anti-EGFR antibody site-specifically modified with a peptide and a chelating agent, wherein the chelating agent is chelated with a metal radionuclide, the peptide and the chelating agent are linked by a linker (L), and the linker (L) does not contain a thiourea bond.
AbstractList 본 발명은, 약효를 손상시키는 일 없이 종래보다도 안정성이 높여진 복합체를 제공하는 것을 과제로 한다. 본 발명의 복합체는, 펩티드로 부위 특이적으로 수식된 항EGFR 항체와 킬레이트제의 복합체이며, 킬레이트제에 방사성 금속 핵종이 킬레이트화되어 있고, 펩티드와 킬레이트제가 링커(L)를 통해 연결되어 있고, 링커(L)는 티오우레아 결합을 포함하지 않는다. A conjugate having stability improved more than conventional conjugates without impairing the efficacy is provided by the present invention. The conjugate of the present invention is a conjugate of an anti-EGFR antibody site-specifically modified with a peptide and a chelating agent, wherein the chelating agent is chelated with a metal radionuclide, the peptide and the chelating agent are linked by a linker (L), and the linker (L) does not contain a thiourea bond.
Author HANADA TAKAHISA
TONOYA GOTA
KAWATANI MINORU
TAKEDA TAKUYA
Author_xml – fullname: KAWATANI MINORU
– fullname: TONOYA GOTA
– fullname: HANADA TAKAHISA
– fullname: TAKEDA TAKUYA
BookMark eNrjYmDJy89L5WSwejt1rau7W5ACkH6zacubuTMUXm9Y-aZpzZuWjQqvN299O3UlUBgo1o8kDlT1ZupeHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oS7x1kZGBkbGBoZmxiYe5oTJwqAFPBQM8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230163487A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230163487A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230163487A3
Notes Application Number: KR20237036890
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231130&DB=EPODOC&CC=KR&NR=20230163487A
ParticipantIDs epo_espacenet_KR20230163487A
PublicationCentury 2000
PublicationDate 20231130
PublicationDateYYYYMMDD 2023-11-30
PublicationDate_xml – month: 11
  year: 2023
  text: 20231130
  day: 30
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies NIHON MEDI-PHYSICS CO., LTD
RelatedCompanies_xml – name: NIHON MEDI-PHYSICS CO., LTD
Score 3.4625995
Snippet 본 발명은, 약효를 손상시키는 일 없이 종래보다도 안정성이 높여진 복합체를 제공하는 것을 과제로 한다. 본 발명의 복합체는, 펩티드로 부위 특이적으로 수식된 항EGFR 항체와 킬레이트제의 복합체이며, 킬레이트제에 방사성 금속 핵종이 킬레이트화되어 있고, 펩티드와 킬레이트제가...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 항EGFR 항체의 방사성 복합체 및 방사성 의약
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231130&DB=EPODOC&locale=&CC=KR&NR=20230163487A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbUwTTQwTANmpBSDJF0Tc_Nk3SRDczPdlFRTYH1uaJhsCL5FwdfPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwMYKsExWc3GydQ3wd_F3VnN2tvUOUvMLAssBWzfGwPa5IzMDK7AhbQ5aAOYa5gTal1KAXKm4CTKwBQDNyysRYmDKzhdm4HSG3b0mzMDhC53yBjKhua9YhMHq7dS1ru5uQQpA-s2mLW_mzlB4vWHlm6Y1b1o2KrzevPXt1JVAYaBYP5I4UNWbqXtFGZTdXEOcPXSBjoiH-zneOwjZxcZiDCx5-XmpEgwKlpYm5kZJZkmW5qnmJklGlomWhkmGJmnJSUmWxsaJBsmSDDL4TJLCLy3NwAXiQs42lGFgKSkqTZUF1rolSXLgwAIAgMSUVg
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbUwTTQwTANmpBSDJF0Tc_Nk3SRDczPdlFRTYH1uaJhsCL5FwdfPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwMYKsExWc3GydQ3wd_F3VnN2tvUOUvMLAssBWzfGwPa5IzMDK7CRbQE6ad81zAm0L6UAuVJxE2RgCwCal1cixMCUnS_MwOkMu3tNmIHDFzrlDWRCc1-xCIPV26lrXd3dghSA9JtNW97MnaHwesPKN01r3rRsVHi9eevbqSuBwkCxfiRxoKo3U_eKMii7uYY4e-gCHREP93O8dxCyi43FGFjy8vNSJRgULC1NzI2SzJIszVPNTZKMLBMtDZMMTdKSk5IsjY0TDZIlGWTwmSSFX1qegdMjxNcn3sfTz1uagQskBTnnUIaBpaSoNFUWWAOXJMmBAw4AncmXRg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%95%ADEGFR+%ED%95%AD%EC%B2%B4%EC%9D%98+%EB%B0%A9%EC%82%AC%EC%84%B1+%EB%B3%B5%ED%95%A9%EC%B2%B4+%EB%B0%8F+%EB%B0%A9%EC%82%AC%EC%84%B1+%EC%9D%98%EC%95%BD&rft.inventor=KAWATANI+MINORU&rft.inventor=TONOYA+GOTA&rft.inventor=HANADA+TAKAHISA&rft.inventor=TAKEDA+TAKUYA&rft.date=2023-11-30&rft.externalDBID=A&rft.externalDocID=KR20230163487A